We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPHQ icon
2976
Invesco S&P 500 Quality ETF
SPHQ
$19.7B
$305K ﹤0.01%
9,200
+1,148
+14% +$37.5K
STK
2977
Columbia Seligman Premium Technology Growth Fund
STK
$923M
$305K ﹤0.01%
14,900
-7,417
-33% -$154K
MCA
2978
DELISTED
BLACKROCK MUNIYIELD CALIFORNIA QUALITY FUND, INC
MCA
$305K ﹤0.01%
21,510
+4,971
+30% +$69K
GT icon
2979
Goodyear
GT
$1.74B
$304K ﹤0.01%
19,846
-24,283
-55% -$410K
PBFX
2980
DELISTED
PBF LOGISTICS LP
PBFX
$304K ﹤0.01%
14,371
+2,639
+22% +$54.6K
BHF icon
2981
Brighthouse Financial
BHF
$3.46B
$303K ﹤0.01%
8,249
-86,312
-91% -$3.33M
TLTE icon
2982
FlexShares Morningstar Emerging Markets Factor Tilt Index Fund
TLTE
$346M
$302K ﹤0.01%
5,824
AGGY icon
2983
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$922M
$301K ﹤0.01%
5,878
+1,000
+21% +$50.2K
HIX
2984
Western Asset High Income Fund II
HIX
$355M
$301K ﹤0.01%
42,834
+9,127
+27% +$60.8K
VRTU
2985
DELISTED
Virtusa Corporation
VRTU
$301K ﹤0.01%
6,769
+488
+8% +$23.8K
NG icon
2986
NovaGold Resources
NG
$3.35B
$299K ﹤0.01%
50,776
+24,428
+93% +$104K
SHAK icon
2987
Shake Shack
SHAK
$2.89B
$299K ﹤0.01%
+4,141
New +$256K
ANIK icon
2988
Anika Therapeutics
ANIK
$277M
$298K ﹤0.01%
7,343
-378
-5% -$13.8K
CVU icon
2989
CPI Aerostructures
CVU
$69.6M
$298K ﹤0.01%
35,400
+400
+1% +$2.82K
PVLA
2990
Palvella Therapeutics
PVLA
$2.19B
$298K ﹤0.01%
791
-63
-7% -$18.8K
TRHC
2991
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$298K ﹤0.01%
5,974
+89
+2% +$4.43K
ACNT icon
2992
Ascent Industries
ACNT
$141M
$297K ﹤0.01%
19,000
ISCG icon
2993
iShares Morningstar Small-Cap Growth ETF
ISCG
$1.01B
$296K ﹤0.01%
8,724
GAIN icon
2994
Gladstone Investment Corp
GAIN
$651M
$295K ﹤0.01%
26,311
+461
+2% +$5.47K
SMMU icon
2995
PIMCO Short Term Municipal Bond Active Exchange-Traded Fund
SMMU
$1.17B
$295K ﹤0.01%
+5,833
New +$294K
MU icon
2996
PUT
Micron Technology
MU
$972B
$294K ﹤0.01%
58,200
-8,200
-12% -$312K
HNP
2997
DELISTED
Huaneng Power Intl, Inc.
HNP
$294K ﹤0.01%
12,622
-615
-5% -$14.9K
IEZ icon
2998
iShares US Oil Equipment & Services ETF
IEZ
$383M
$293K ﹤0.01%
13,493
-58
-0.4% -$1.33K
PGNX
2999
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$293K ﹤0.01%
47,485
-10,336
-18% -$49.8K
BSCS icon
3000
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.58B
$292K ﹤0.01%
+13,510
New +$283K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.